Sylvie Lhoste

Managing Editor of @EuroInterventio & @AsiaInterv

[EuroIntervention @EuroInterventio]

☀️Editor's Choice is taking a short summer break!

Thank you to everyone who has listened to and supported the podcast since the launch.

If you have missed any recent episodes, now is the perfect time to catch up on our latest podcast episodes, as @aayshacader sits down with leading experts to discuss the latest research in interventional cardiology.

🎧8 episodes are available: https://t.co/4oS3qW9svj

We'll return after the summer with brand-new episodes.

#InterventionalCardiology #CardioEducation #CardioEd @PCRonline

[EuroIntervention @EuroInterventio]

In the pilot STOP-IMH randomised trial, immediate ticagrelor monotherapy after primary #PCI for #STEMI showed no apparent excess in 1-year ischaemic events while significantly reducing non-access site bleeding compared with #DAPT.

Read more here: https://t.co/0OIez0EN3L

@BimmerClaessen @NielsRoyen @RGeuns @RNijveldt

[EuroIntervention @EuroInterventio]

Does PCI complexity matter when selecting antiplatelet therapy after #PCI for #ACS?
This post hoc analysis of the NEO-MINDSET trial found that PCI complexity did not modify the effects of potent #P2Y12 inhibitor monotherapy versus #DAPT on ischaemic or bleeding outcomes. Monotherapy reduced clinically relevant bleeding, but without a clear net clinical benefit.
Read original article: https://t.co/lhwtiQWZUw

Editorial: https://t.co/FPhHJngNLx

@GuyPrado19769 @caiodeamtavares @valeriaparadies @BrenoOl52003987

[EuroIntervention @EuroInterventio]

Temporal trends from the PRIME-MR registry show continuous improvements in mitral TEER for primary MR.
Over time, procedural complications decreased, residual MR was reduced, and 1-year durability improved in a large real-world cohort of >3,000 patients.
https://t.co/DLe0x9eBay

@BenediktKoell @DaryoushSamim @philippvstein @AndreaScotti21 @Jmparadis27 @nickaram @yohann_bohbot @EdithLubos @azeemlatib @chriliadis @FabienPraz @jgranadacrf @modine_thomas @j_hausleiter @AugustinCoisne
@DanielKalbacher

#MitralValve #MitraClip #StructuralHeart #Cardiology #TEER #Cardioed

[EuroIntervention Case Reports @EIJCaseReports]

📗 EIJ Case Reports – First cases available! 
🎥 Listen to Deputy Editors @valeriaparadies & @AndreaScotti21 answer questions on the recently-launched reference case report journal in #interventionalcardiology #cardiology #PCI
@sbrugaletta @dmylotte @PCRonline @EuroInterventio

[EuroIntervention @EuroInterventio]

Can intraprocedural haemodynamics improve risk stratification after M-TEER?
In the OCEAN-Mitral registry, a reduction in mean left atrial pressure during M-TEER was independently associated with better long-term outcomes in degenerative MR, but not in functional MR, uggesting the potential value of real-time physiological assessment beyond MR reduction alone

https://t.co/Ec7fb6rDSl

#MitraClip #TEER #MitralRegurgitation #HeartFailure #StructuralHeart

[EuroIntervention @EuroInterventio]

How should DAPT be tailored after ACS?
This Clinical Consensus Statement synthesises the available evidence and offers a practical framework for selecting antithrombotic strategies based on bleeding and ischaemic risk after PCI.

https://t.co/EmxXmWACT2

@GianlucaCampo78
@TogeislerMD
@BruGig
@DrErikGrove
@sighalvo
@ElianoNavarese
@vlgmrc
@CVandenbriele
@ingo_ahrens

[EuroIntervention @EuroInterventio]

Can ticagrelor monotherapy be considered after PCI in patients with chronic coronary syndrome at high ischaemic risk?
In this post hoc analysis of the TWILIGHT trial, ticagrelor monotherapy after 3 months of DAPT showed similar ischaemic and bleeding outcomes to continued ticagrelor-based DAPT in patients both with and without high ischaemic risk.

https://t.co/MNz1LroDR5

[EuroIntervention @EuroInterventio]

How should transvalvular gradients be assessed after TAVI?
This propensity score-matched study found that invasively measured gradients, but not echocardiography-derived gradients, independently predicted mortality, highlighting the potential prognostic value of invasive haemodynamic assessment after valve implantation. `
🔗https://t.co/Nb5dAvZLpB

#TAVI #StructuralHeart #Hemodynamics #EIJBestOf

@RikAdrMD @verhemel @Rjnuis @drnvanmieghem

[EuroIntervention @EuroInterventio]

Discover our #EIJBestOf

A comprehensive overview of how multimodality imaging characterizes plaque biology, identifies high-risk lesions, and tracks therapeutic response.

🔗https://t.co/LRoFQDLtv8

@hect2701 @sjorge4 @christosbouran1

[EuroIntervention @EuroInterventio]

Does timing of ventricular unloading matter in STEMI-related cardiogenic shock?
New registry data and an accompanying Editorial explore whether "door-to-unload" may emerge as an important metric in shock care.

👉Original Article https://t.co/kaWfTT2bwA

👉Editorial https://t.co/40t8vxlEax

#CardiogenicShock #STEMI #MechanicalCirculatorySupport #InterventionalCardiology

@BenediktSchrage

[EuroIntervention @EuroInterventio]

Intravascular imaging-guided PCI was associated with a significantly lower risk of target vessel failure compared with angiography-guided PCI across all levels of lesion complexity, with increasing prognostic benefit in more complex disease.
Pooled analysis of 4,611 patients from RENOVATE-COMPLEX PCI and registry data.
#EIJBestOf #PCI #IntravascularImaging #InterventionalCardiology

🔗https://t.co/cHU1S5xYsx

[EuroIntervention @EuroInterventio]

Slow flow and no reflow remain major unresolved challenges after PCI, particularly in STEMI.

Discover our State-of-the-Art review by @sbrugaletta et al exploring the mechanisms, diagnosis, and current treatment strategies

https://t.co/UaXeekKr5i

#STEMI #PCI #NoReflow #InterventionalCardiology

[EuroIntervention @EuroInterventio]

The new issue of EuroIntervention is now available.

✅AnchorMan vs Watchman for LAA closure,
✅Self-expanding TAVI valves,
✅Prosthesis-patient mismatch,
✅VARC-HBR validation,
✅Percutaneous aspiration for infective endocarditis,
✅Concomitant TAVI-TMVR,
and more.

🔗https://t.co/kIT59X4dfu

@DrGarot @Nielsen_Kudsk @AMaznyczka @winghostnb @EmanueleBarba13 @NahyrLugo @aelsab

[EuroIntervention @EuroInterventio]

The SAFE-PROTECT randomized trial demonstrated that the novel AnchorMan device was non-inferior to Watchman 2.5 for 12-month clinical success and left atrial appendage closure, with improved sealing performance reflected by fewer clinically relevant peridevice leaks.

https://t.co/7c6JDkZEWn

@winghostnb @AlexandraLansky

[EuroIntervention @EuroInterventio]

In the PORTICO IDE trial, haemodynamic performance was similar between intra-annular and supra-annular self-expanding TAVI valves.
Compared with the balloon-expandable SAPIEN 3, the intra-annular Portico valve was associated with lower prosthesis-patient mismatch across annular sizes.

https://t.co/qNnHqk7PFy

@ron_waksman @Herms2James @n_kleiman @NWeissmanMD @PaulMahoneyMD

[EuroIntervention @EuroInterventio]

In the multicentre CLEAR-IE registry, percutaneous mechanical aspiration for left-sided infective endocarditis was feasible, achieved high procedural success, and showed an acceptable safety profile in a highly complex patient population.
Read more here: https://t.co/UlbXFzLItA

@NahyrLugo @benhibbertMDPhD @PedroMDMSc @SripalBangalore @MohammedQintar @SEH_MD @psorajja @HamidNadira @PradeepYadavMD @sahilparikhmd @aelsab

[EuroIntervention @EuroInterventio]

A single-session transfemoral TAVI and transfemoral/transseptal TMVR using dedicated devices was successfully performed in a patient with complex multivalvular disease, demonstrating the potential of a fully transcatheter treatment strategy in selected cases.

https://t.co/lchUvwlUUE

#TAVI #TMVR #StructuralHeart #InterventionalCardiology

@drtpatterson

[EuroIntervention @EuroInterventio]

The HERA-TAVI registry provided contemporary real-world evidence that intra-annular and supra-annular self-expanding TAVI platforms offer comparable 1-year outcomes, while exhibiting distinct procedural trade-offs that may inform valve selection.

🔗https://t.co/aSHMbzjBnH

#cardioed #StructuralHeart #InterventionalCardiology

@kiadeb87 @P_Paolisso @EGallinoro @DrArifK @AndreaScotti21 @MdMontalto @barbanti_marco @dipietro_elena @gpussia @gabor_gt @elinico5 @attilioleone1 @belmontemarta1 @didier_tchetche @azeemlatib @EmanueleBarba13

[EuroIntervention @EuroInterventio]

From coronary physiology and PCI timing to coronary re-access and coronary obstruction prevention, this State-of-the-Art review provides practical guidance for managing coronary interventions in patients undergoing TAVI. 🔗https://t.co/SjF9384oBS #TAVI #CoronaryInterventions #StructuralHeartDisease

@GilbertTangMD

@didier_tchetche

@barbanti_marco
@AnderRegueiro
@nicolo_piazza
@G_Tarantini01